LONDON | MADRID | KENTUCKY
+34 91 3459395 | +44 (0) 20 3951 80714567890
info@OxonEpi.com

FREE LIVE ONLINE WEBINAR SERIES ON RWE

Unlocking Success: Mastering RWE Studies in the Healthcare Landscapes of Asia, Europe & the US

Free Live Online Webinar Series on RWE

Exploring the complexities of healthcare systems
for develping expertise in your Real-World Evidence studies

A series to delve into the heart of healthcare systems and data sources across diverse countries to empower proficiency in Real-World field, secondary data and hybrid studies.

Sessions delivered by leading pharmacoepidemiologists together with OXON.

Centred on understanding healthcare and data sources to enhance the quality of RWE studies.

Practical cases and tips for  application in safety, HEOR/market access and marketing purposes.

Complemented with specialized sessions covering specific topics related to Real-World Evidence.

Open webinars

Thursday, 24 October2024

Session 05
Mastering RWE Studies in the Healthcare Landscape of Italy

KEY SPEAKER: Prof. Carlo Giaquinto  
Professor of Paediatrics at the Department for Woman’s and Child’s Health of the University of Padua and President of the Penta foundation.

REGISTER HERE

Past Webinars

Explore our previous sessions on mastering Real-World Evidence (RWE) studies, featuring prominent speakers discussing country-specific RWE strategies. Request the slides for deeper insights!

Thursday, 09 May 2024

Session 01
Mastering RWE Studies in the Healthcare Landscape of South Korea

KEY SPEAKER: Dr Ju Hwan Kim
Research Assistant Professor of Pharmacoepidemiology and Pharmacovigilance, School of Pharmacy, Sungkyunkwan University, South Korea.

REQUEST FOR SLIDES

Wednesday, 26 June 2024

Session 02
Mastering RWE Studies in the Healthcare Landscape of The UK

KEY SPEAKER: Prof. Tom MacDonald
Professor of Clinical Pharmacology & Pharmacoepidemiology, University of Dundee, and Honorary Consultant Physician at Ninewells Hospital and Medical School.

REQUEST FOR SLIDES

Thursday, 11 July 2024

Session 03
Mastering RWE Studies in the Healthcare Landscape of Japan

KEY SPEAKER: Prof. Masao Iwagami
Clinical Epidemiologist and Professor at the University of Tsukuba, and Honorary Assistant Professor of Epidemiology and Population Health at the LSHTM.

REQUEST FOR SLIDES

Thursday, 19 September 2024

Session 04
Mastering RWE Studies in the Healthcare Landscape of France

KEY SPEAKER: Dr Patrick Blin
Pharmaco-Epi Senior Consultant, SNDS expert and Vice-president of the Ethics and Scientific Committee for Health Research, Studies and Evaluations (CESREES)

REQUEST FOR SLIDES

Other topics in the Programme

Other sessions of this Webinar series include topics, such as:

Mastering RWE Studies in the Healthcare Landscape of the US
Mastering RWE Studies in the Healthcare Landscape of Germany
Mastering RWE Studies in the Healthcare Landscape of Taiwan
Mastering RWE Studies in the Healthcare Landscape of the Nordics
Mastering RWE Studies: Pregnancy
Mastering RWE Studies: Evaluation of RMMs
 Mastering RWE Studies: Multi-Country RW Secondary Data Studies

REGISTER FOR UPDATES

Meet the experts

This webinar series will be delivered by OXON Epidemiology and top-tier academics to provide a phased educational experience in which to learn about conducting optimal data collection and secondary data observational studies of different types for safety, market access/HEOR and clinical development in major therapy areas, orphan conditions and pregnancy.

OXON EPIDEMIOLOGY
Your observational studies service provider

Let us help design & conduct your optimal
PASS or Outcomes observational study

OXON epidemiologists, statisticians, clinicians, and project managers (ex-big pharma), supported by Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine (devised: ‘Pocock Stopping Rule’, ‘Win Ratio’. ‘Individualising benefit-risk’); extensive experience with EMA/FDA and data monitoring committees (including adaptive platform Covid-19 DISCOVERY trial); >600 publications (100+ NEJM/Lancets)

REQUEST A MEETING